Dr. Julhash Uddin Kazi
My Social Links

Dr. Julhash Uddin Kazi

Senior Scientist
Lund University, Sweden


Highest Degree
Ph.D. in Biochemistry from Lund University, Sweden

Share this Profile

Biography

Dr. Julhash Uddin Kazi is currently working as Senior Scientist at Lund University, Sweden. He has completed his Ph.D. in Biochemistry and Post Doctorate from same University. Previously he was appointed as Quality Control In-Charge at Opsonin Pharma Limited, and Teaching Assistant and Research Assistant at Inha University. He is member of European Hematology Association, American Association for Cancer Research, American Society for Cell Biology, and NITUB Bangladesh. He has published 43 research articles in journals contributed as author/co-author. He also received number of grants for his research work.

Area of Interest:

Chemistry
100%
Cancer Research
62%
Protein Kinases
90%
Molecular Biology
75%
Biochemistry
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Lindblad, O., E. Cordero, A. Puissant, L. Macaulay and R. Ramos et al., 2016. Activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML. Oncogene. .
    Direct Link  |  
  2. Chougule, R.A., J.U. Kazi and L. Ronnstrand, 2016. FYN expression potentiates FLT3-ITD induced STAT5 signaling in acute myeloid leukemia. Oncotarget. 10.18632/oncotarget.7128.
    CrossRef  |  Direct Link  |  
  3. Chougule, R.A., E. Cordero, S.A. Moharram, K. Pietras, L. Ronnstrand and J.U. Kazi, 2016. Expression of GADS enhances FLT3-induced mitogenic signaling. Oncotarget. 10.18632/oncotarget.7415.
    CrossRef  |  Direct Link  |  
  4. Alam, M.W., C.U. Persson, S. Reinbothe, J.U. Kazi and L. Ronnstrand et al., 2016. HIF2α contributes to antiestrogen resistance via positive bilateral crosstalk with EGFR in breast cancer cells. Oncotarget. 10.18632/oncotarget.7167.
    CrossRef  |  Direct Link  |  
  5. Zhang, J., O. Vakhrusheva, S.R. Bandi, O. Demirel and J.U. Kazi et al., 2015. The phosphatases STS1 and STS2 regulate hematopoietic stem and progenitor cell fitness. Stem Cell Rep., 5: 633-646.
    CrossRef  |  Direct Link  |  
  6. Lindblad, O., T. Li, X. Su, J. Sun and N.N. Kabir et al., 2015. BEX1 acts as a tumor suppressor in acute myeloid leukemia. Oncotarget, 6: 21395-21405.
    CrossRef  |  Direct Link  |  
  7. Lindblad, O., R.A. Chougule, S.A. Moharram, N.N. Kabir, J. Sun, J.U. Kazi and L. Ronnstrand, 2015. The role of HOXB2 and HOXB3 in acute myeloid leukemia. Biochem. Biophys. Res. Commun., 467: 742-747.
    CrossRef  |  Direct Link  |  
  8. Lindblad, O., J.U. Kazi, L. Ronnstrand and J. Sun, 2015. PI3 kinase is indispensable for oncogenic transformation by the V560D mutant of c-Kit in a kinase-independent manner. Cell. Mol. Life Sci., 72: 4399-4407.
    CrossRef  |  PubMed  |  
  9. Kazi, J.U., N.N. Kabir and L. Ronnstrand, 2015. Role of SRC-Like Adaptor Protein (SLAP) in immune and malignant cell signaling. Cell. Mol. Life Sci., 72: 2535-2544.
    CrossRef  |  Direct Link  |  
  10. Kazi, J.U., N.N. Kabir and L. Ronnstrand, 2015. Brain-Expressed X-linked (BEX) proteins in human cancers. Biochim. Biophys. Acta (BBA)-Rev. Cancer, 1856: 226-233.
    CrossRef  |  Direct Link  |  
  11. Kazi, J.U., A. Flores-Morales and L. Ronnstrand, 2015. SOCS6 (suppressor of cytokine signaling 6). Atlas Genet. Cytogenet. Oncol. Haematol., 19: 50-52.
    CrossRef  |  
  12. Agarwal, S., J.U. Kazi, S. Mohlin, S. Pahlman and L. Ronnstrand, 2015. The activation loop tyrosine 823 is essential for the transforming capacity of the c-Kit oncogenic mutant D816V. Oncogene, 34: 4581-4590.
    CrossRef  |  Direct Link  |  
  13. Sun, J., S. Mohlin, A. Lundby, J.U. Kazi and U. Hellman et al., 2014. The PI3-kinase isoform p110δ is essential for cell transformation induced by the D816V mutant of c-Kit in a lipid-kinase-independent manner. Oncogene, 33: 5360-5369.
    CrossRef  |  Direct Link  |  
  14. Puissant, A., N. Fenouille, G. Alexe, Y. Pikman and C.F. Bassil et al., 2014. SYK Is a critical regulator of FLT3 in acute myeloid leukemia. Cancer Cell, 25: 226-242.
    CrossRef  |  Direct Link  |  
  15. Kazi, J.U., S. Agarwal, J. Sun, E. Bracco and L. Ronnstrand, 2014. Src-Like Adaptor Protein (SLAP) differentially regulates normal and oncogenic c-Kit signaling. J. Cell Sci., 127: 653-662.
    CrossRef  |  Direct Link  |  
  16. Kazi, J.U., N.N. Kabir, A. Flores-Morales and L. Ronnstrand, 2014. SOCS proteins in regulation of receptor tyrosine kinase signaling. Cell. Mol. Life Sci., 71: 3297-3310.
    Direct Link  |  
  17. Kabir, N.N., L. Ronnstrand and J.U. Kazi, 2014. Keratin 19 expression correlates with poor prognosis in breast cancer. Mol. Biol. Rep., 41: 7729-7735.
    CrossRef  |  Direct Link  |  
  18. Kabir, N.N., J. Sun, L. Ronnstrand and J.U. Kazi, 2014. SOCS6 is a selective suppressor of receptor tyrosine kinase signaling. Tumor Biol., 35: 10581-10589.
    Direct Link  |  
  19. Kabir, N.N. and J.U. Kazi, 2014. Grb10 is a dual regulator of receptor tyrosine kinase signaling. Mol. Biol. Rep., 41: 1985-1992.
    Direct Link  |  
  20. Kazi, J.U., N.N. Kabir and L. Ronnstrand, 2013. Protein Kinase C (PKC) as a drug target in chronic lymphocytic leukemia. Med. Oncol., 30: 1-8.
    Direct Link  |  
  21. Kazi, J.U., M. Vaapil, S. Agarwal, E. Bracco, S. Pahlman and L. Ronnstrand, 2013. The tyrosine kinase CSK associates with FLT3 and c-Kit receptors and regulates downstream signaling. Cell. Signal., 25: 1852-1860.
    CrossRef  |  Direct Link  |  
  22. Kazi, J.U. and L. Ronnstrand, 2013. Suppressor of cytokine signaling 2 (SOCS2) associates with FLT3 and negatively regulates downstream signaling. Mol. Oncol., 7: 693-703.
    CrossRef  |  Direct Link  |  
  23. Kazi, J.U. and L. Ronnstrand, 2013. FLT3 signals via the adapter protein Grb10 and overexpression of Grb10 leads to aberrant cell proliferation in acute myeloid leukemia. Mol. Oncol., 7: 402-418.
    CrossRef  |  Direct Link  |  
  24. Kabir, N.N., L. Ronnstrand and J.U. Kazi, 2013. The basic helix-loop-helix (bHLH) proteins in breast cancer progression. Med. Oncol., 30: 1-3.
    Direct Link  |  
  25. Kabir, N.N., L. Ronnstrand and J.U. Kazi, 2013. Protein Kinase C (PKC) expression is deregulated in chronic lymphocytic leukemia. Leukemia Lymphoma, 54: 2288-2290.
    CrossRef  |  Direct Link  |  
  26. Kabir, N.N., L. Ronnstrand and J.U. Kazi, 2013. FLT3 mutations in patients with childhood Acute Lymphoblastic Leukemia (ALL). Med. Oncol., 30: 462-462.
  27. Kabir, N.N., L. Ronnstrand and J.U. Kazi, 2013. Deregulation of protein phosphatase expression in acute myeloid leukemia. Med. Oncol., 30: 1-6.
    Direct Link  |  
  28. Kabir, N.N. and J.U. Kazi, 2013. Selective mutation in ATP-binding site reduces affinity of drug to the kinase: A possible mechanism of chemo-resistance. Med. Oncol., 30: 448-448.
  29. Agarwal, S., J.U. Kazi and L. Ronnstrand, 2013. Phosphorylation of the activation loop tyrosine 823 in c-Kit is crucial for cell survival and proliferation. J. Biol. Chem., 288: 22460-22468.
    CrossRef  |  Direct Link  |  
  30. Lin, D.C., T. Yin, M. Koren-Michowitz, L.W. Ding and S. Gueller et al., 2012. Adaptor protein Lnk binds to and inhibits normal and leukemic FLT3. J. Am. Soc. Hematol., 120: 3310-3317.
    CrossRef  |  PubMed  |  Direct Link  |  
  31. Kazi, J.U., J. Sun, B. Phung, F. Zadjali and A. Flores-Morales et al., 2012. Suppressor of Cytokine Signaling 6 (SOCS6) Negatively Regulates Flt3 Signal Transduction Through Direct Binding to Phosphorylated Tyrosines 591 and 919 of Flt3. J. Biol. Chem., 287: 36509-36517.
    CrossRef  |  PubMed  |  Direct Link  |  
  32. Kazi, J.U. and L. Ronnstrand, 2012. Src-Like Adaptor Protein (SLAP) binds to the receptor tyrosine kinase Flt3 and modulates receptor stability and downstream signaling. PLoS One, Vol. 7. 10.1371/journal.pone.0053509.
    CrossRef  |  Direct Link  |  
  33. Khan, M.M.G., A.M. Ryden, M.S. Chowdhury, M.A. Hasan and J.U. Kazi, 2011. Maximum likelihood analysis of mammalian p53 indicates the presence of positively selected sites and higher tumorigenic mutations in purifying sites. Gene, 483: 29-35.
    CrossRef  |  PubMed  |  Direct Link  |  
  34. Kazi, J.U., 2011. The mechanism of protein kinase C regulation. Front Biol., 6: 328-336.
    CrossRef  |  Direct Link  |  
  35. Kabir, N.N., M.I. Hossain and J.U. Kazi, 2011. Comparative studies on human and rat basic Helix-loop-helix proteins. Asian J. Biol. Sci., 4: 601-608.
    CrossRef  |  Direct Link  |  
  36. Kabir, N.N. and J.U. Kazi, 2011. Comparative analysis of human and bovine protein kinases reveals unique relationship and functional diversity. Genet. Mol. Biol., 34: 587-591.
    CrossRef  |  PubMed  |  Direct Link  |  
  37. Kim, H.J., J.U. Kazi, Y.R. Lee, D.H. Nguyen and H.B. Lee et al., 2010. Visualization of the melanosome transfer-inhibition in a mouse epidermal cell co-culture model. Int. J. Mol. Med., 25: 249-253.
    CrossRef  |  PubMed  |  Direct Link  |  
  38. Kazi, J.U., C.R. Kim and J.W. Soh, 2009. Subcellular localization of diacylglycerol-responsive protein kinase C isoforms in HeLa cells. Bull. Korean Chem. Soc., 30: 1981-1984.
    Direct Link  |  
  39. Soh, J.W., J.U. Kazi, H. Li, W.J. Thompson and I.B. Weinstein, 2008. Celecoxib-induced growth inhibition in SW480 colon cancer cells is associated with activation of protein kinase G. Mol. Carcinogenesis, 47: 519-525.
    CrossRef  |  PubMed  |  Direct Link  |  
  40. Kazi, J.U., N.N. Kabir and J.W. Soh, 2008. Bioinformatic prediction and analysis of eukaryotic protein kinases in the rat genome. Gene, 410: 147-153.
    CrossRef  |  PubMed  |  Direct Link  |  
  41. Kazi, J.U. and J.W. Soh, 2008. Role of regulatory domain mutants of PKC isoforms in c-fos induction. Bull. Korean Chem. Soc., 29: 252-254.
  42. Kazi, J.U. and J.W. Soh, 2008. Induction of the nuclear proto-oncogene c-fos by the phorbol ester TPA and c-H-Ras. Mol. Cells, 26: 462-467.
    PubMed  |  Direct Link  |  
  43. Kazi, J.U. and J.W. Soh, 2007. Isoform-specific translocation of PKC isoforms in NIH3T3 cells by TPA. Biochem. Biophys. Res. Commun., 364: 231-237.
    CrossRef  |  PubMed  |  Direct Link  |